CLINICAL TRIAL ARTICLE CyTOF® mass cytometry findings could help identify a subset of patients with castration-resistant prostate cancer (CRPC) that are suited for checkpoint inhibitors therapy. "Phase II Study of Ipilimumab in Men…https://t.co/tr2AQ8gy5z
193 followers
906 followers
New article: Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy. https://t.co/RRMVlRX0gl #prostatecancer #oncology https://t.co/7O79XkXDaD
602 followers
Frontiers | Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation Therapy | Oncology #cytofpub https://t.co/wFsLKClTG1